Caroline Dive

Caroline Dive Caroline Dive (born April 1962) is a British cancer research scientist. Dive is Professor of Cancer Pharmacology at the University of Manchester, Deputy Director of the Cancer Research UK (CRUK) Manchester Institute, Director of the CRUK Manchester Institute Cancer Biomarker Centre and co-director of the CRUK Lung Cancer Centre of Excellence. She is the current president of The European Association for Cancer Research (EACR).

Dive's citation upon election as Fellow of the Academy of Medical Sciences describes her as internationally renowned for her work on the development of liquid biopsy methods which use biomarkers circulating in the blood, such as circulating tumour cells and cell-free tumour DNA, to diagnose and monitor cancer. Provided by Wikipedia
Showing 1 - 20 results of 25 for search 'Caroline Dive', query time: 0.07s Refine Results
  1. 1
    Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.

    Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha. by Jennifer Adamski, Andrew Price, Caroline Dive, Guy Makin

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Increases in c-Yes Expression Level and Activity Promote Motility But Not Proliferation of Human Colorectal Carcinoma Cells

    Increases in c-Yes Expression Level and Activity Promote Motility But Not Proliferation of Human Colorectal Carcinoma Cells by Jane Barraclough, Cassandra Hodgkinson, Alison Hogg, Caroline Dive, Arkadiusz Welman

    Published 2007-09-01
    Get full text
    Article
  3. 3
    A model of k-mer surprisal to quantify local sequence information content surrounding splice regions

    A model of k-mer surprisal to quantify local sequence information content surrounding splice regions by Sam Humphrey, Alastair Kerr, Magnus Rattray, Caroline Dive, Crispin J. Miller

    Published 2020-11-01
    Get full text
    Article
  4. 4
    Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights

    Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights by Francesca Chemi, Sumitra Mohan, Tatiana Guevara, Alexandra Clipson, Dominic G. Rothwell, Caroline Dive

    Published 2021-05-01
    Get full text
    Article
  5. 5
    Progress and prospects of early detection in lung cancer

    Progress and prospects of early detection in lung cancer by Sean Blandin Knight, Phil A. Crosbie, Haval Balata, Jakub Chudziak, Tracy Hussell, Caroline Dive

    Published 2017-01-01
    Get full text
    Article
  6. 6
    Circulating Tumor Cells, Enumeration and Beyond

    Circulating Tumor Cells, Enumeration and Beyond by Jian-Mei Hou, Matthew Krebs, Tim Ward, Karen Morris, Robert Sloane, Fiona Blackhall, Caroline Dive

    Published 2010-06-01
    Get full text
    Article
  7. 7
    Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories

    Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories by Robert E. Hynds, Kristopher K. Frese, David R. Pearce, Eva Grönroos, Caroline Dive, Charles Swanton

    Published 2021-01-01
    Get full text
    Article
  8. 8
    BMX Acts Downstream of PI3K to Promote Colorectal Cancer Cell Survival and Pathway Inhibition Sensitizes to the BH3 Mimetic ABT-737

    BMX Acts Downstream of PI3K to Promote Colorectal Cancer Cell Survival and Pathway Inhibition Sensitizes to the BH3 Mimetic ABT-737 by Danielle S. Potter, Paul Kelly, Olive Denneny, Veronique Juvin, Len R. Stephens, Caroline Dive, Christopher J. Morrow

    Published 2014-02-01
    Get full text
    Article
  9. 9
    DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer

    DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer by Ruth E Board, Lucy Knight, Alastair Greystoke, Fiona H Blackhall, Andrew Hughes, Caroline Dive5, Malcolm Ranson

    Published 2007-01-01
    Get full text
    Article
  10. 10
    Interrogating the precancerous evolution of pathway dysfunction in lung squamous cell carcinoma using XTABLE

    Interrogating the precancerous evolution of pathway dysfunction in lung squamous cell carcinoma using XTABLE by Matthew Roberts, Julia Ogden, AS Mukarram Hossain, Anshuman Chaturvedi, Alastair RW Kerr, Caroline Dive, Jennifer Ellen Beane, Carlos Lopez-Garcia

    Published 2023-03-01
    Get full text
    Article
  11. 11
    Plasticity of circulating tumor cells in small cell lung cancer

    Plasticity of circulating tumor cells in small cell lung cancer by Jiyoun Seo, Mihir Kumar, Jeremy Mason, Fiona Blackhall, Nicholas Matsumoto, Caroline Dive, James Hicks, Peter Kuhn, Stephanie N. Shishido

    Published 2023-07-01
    Get full text
    Article
  12. 12
    Somatically mutated ABL1 is an actionable and essential NSCLC survival gene

    Somatically mutated ABL1 is an actionable and essential NSCLC survival gene by Ewelina Testoni, Natalie L Stephenson, Pedro Torres‐Ayuso, Anna A Marusiak, Eleanor W Trotter, Andrew Hudson, Cassandra L Hodgkinson, Christopher J Morrow, Caroline Dive, John Brognard

    Published 2016-02-01
    Get full text
    Article
  13. 13
    Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value

    Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value by Michael J. Walker, Cong Zhou, Alison Backen, Maria Pernemalm, Andrew J.K. Williamson, Lynsey J.C. Priest, Pek Koh, Corinne Faivre-Finn, Fiona H. Blackhall, Caroline Dive, Anthony D. Whetton

    Published 2015-08-01
    Get full text
    Article
  14. 14
    Evaluation of apoptosis imaging biomarkers in a genetic model of cell death

    Evaluation of apoptosis imaging biomarkers in a genetic model of cell death by Vessela Vassileva, Stephen M. Stribbling, Chris Barnes, Laurence Carroll, Marta Braga, Joel Abrahams, Kathrin Heinzmann, Caroline Haegeman, Marion MacFarlane, Kathryn L. Simpson, Caroline Dive, Jamie Honeychurch, Timothy M. Illidge, Eric O. Aboagye

    Published 2019-02-01
    Get full text
    Article
  15. 15
    A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs

    A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs by Yan Ting Shue, Alexandros P. Drainas, Nancy Yanzhe Li, Sarah M. Pearsall, Derrick Morgan, Nasa Sinnott-Armstrong, Susan Q. Hipkins, Garry L. Coles, Jing Shan Lim, Anthony E. Oro, Kathryn L. Simpson, Caroline Dive, Julien Sage

    Published 2022-05-01
    Get full text
    Article
  16. 16
    Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer

    Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer by Maximilian W. Schenk, Sam Humphrey, A. S. Md Mukarram Hossain, Mitchell Revill, Sarah Pearsall, Alice Lallo, Stewart Brown, Samuel Bratt, Melanie Galvin, Tine Descamps, Cong Zhou, Simon P. Pearce, Lynsey Priest, Michelle Greenhalgh, Anshuman Chaturvedi, Alastair Kerr, Fiona Blackhall, Caroline Dive, Kristopher K. Frese

    Published 2021-11-01
    Get full text
    Article
  17. 17
    A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

    A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary by Alicia-Marie Conway, Simon P. Pearce, Alexandra Clipson, Steven M. Hill, Francesca Chemi, Dan Slane-Tan, Saba Ferdous, A. S. Md Mukarram Hossain, Katarzyna Kamieniecka, Daniel J. White, Claire Mitchell, Alastair Kerr, Matthew G. Krebs, Gerard Brady, Caroline Dive, Natalie Cook, Dominic G. Rothwell

    Published 2024-04-01
    Get full text
    Article
  18. 18
    FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy

    FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy by Ian G. Cannell, Kirsty Sawicka, Isabella Pearsall, Sophia A. Wild, Lauren Deighton, Sarah M. Pearsall, Giulia Lerda, Fadwa Joud, Showkhin Khan, Alejandra Bruna, Kathryn L. Simpson, Claire M. Mulvey, Fiona Nugent, Fatime Qosaj, Dario Bressan, Caroline Dive, Carlos Caldas, Gregory J. Hannon

    Published 2023-08-01
    Get full text
    Article
  19. 19
    Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study

    Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study by Reem D. Mahmood, Danielle Shaw, Tine Descamps, Cong Zhou, Robert D. Morgan, Saifee Mullamitha, Mark Saunders, Nerissa Mescallado, Alison Backen, Karen Morris, Ross A. Little, Susan Cheung, Yvonne Watson, James P. B. O’Connor, Alan Jackson, Geoff J. M. Parker, Caroline Dive, Gordon C. Jayson

    Published 2021-04-01
    Get full text
    Article
  20. 20
    Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer

    Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer by Nadine S. Jahchan, Jing Shan Lim, Becky Bola, Karen Morris, Garrett Seitz, Kim Q. Tran, Lei Xu, Francesca Trapani, Christopher J. Morrow, Sandra Cristea, Garry L. Coles, Dian Yang, Dedeepya Vaka, Michael S. Kareta, Julie George, Pawel K. Mazur, Thuyen Nguyen, Wade C. Anderson, Scott J. Dylla, Fiona Blackhall, Martin Peifer, Caroline Dive, Julien Sage

    Published 2016-07-01
    Get full text
    Article

Search Tools: